To the Editor: I was delighted to see the editorial entitled "Immediate Arteriography in Strokes" in the December 6 issue of the Journal. The importance of considering arteriography as part of the ...

RenovoRx, Inc. ("RenovoRx" or the "Company") , a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath, a novel, FDA-cleared drug-delivery device, today ...

Prospective data for the transradial approach for cerebral arteriography are lacking. Objective To carry out a prospective study of consecutive patients undergoing transradial cerebral arteriography ...

Screening: CT angiography (CTA) is the preferred screening tool for BCVI. Four-vessel biplanar cerebral arteriography, duplex ultrasonography, and MRI are not recommended as screening tools.

Conventional contrast arteriography is utilized by most centers as the standard diagnostic tool for confirming subclavian occlusive disease with treatment planned at the time of diagnostic ...

RenovoRx (NASDAQ: RNXT) , a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath(R), a novel, FDA-cleare ...

RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing ...

The pediatric population spans a diverse age group,1 from neonates and infants to adult-sized teenagers, each with unique physiological characteristics that must be considered when performing ...

Objective: We set out to analyze the incidence and predictive factors of pulmonary embolism (PE) in hospitalized patients with Covid-19. Methods: We prospectively collected data from all consecutive ...

Since the size of the involved vessels in small-vessel vasculitis (200–500 μm) is smaller than the resolution capability of digital subtraction arteriography (DSA), false-negative results are ...

RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath, an innovative, FDA-cleared device, ...

1 Department of Rheumatology and Immunology, Peking University International Hospital, Beijing, China 2 Department of Pathology, Peking University International Hospital, Beijing, China ...